Sales Revenues Increase Primarily on Kidz-Med Thermofocus(R) 5-in-1
WESTON, Fla., May 11 /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. today announced unaudited revenue results for the first quarter ending March 31, 2009.
The Company experienced a 15% sales increase with net sales of $263,603 for the first quarter of 2009, as compared to net sales of $229,982 for the first quarter of 2008.
The sales increase was predominantly due to a boost in online sales of the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer, Pacifier Medicine Dispenser and other products supplied by Kidz-Med. The increase in revenue was also based upon the introduction of the Kidz-Med Thermofocus 5-in-1 in 157 of the world’s leading toy and baby products stores.
Awareness was created through social media and organic and amplified word of mouth marketing to assist in driving traffic to the distribution channels listed as well as Walgreens, BabiesRUs.com and CVS.com.
Management expects this upward trend to continue and even accelerate as a result of the September 2008 introduction of the Thermofocus 5-in-1 to consumers via the world’s largest specialty baby retailer.
Management hopes to have the audit of the 2008 financials and Q1 2009 review completed shortly.
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is a holding company for two wholly owned subsidiaries, Kidz-Med, Inc. and Heart Smart System. The Company’s objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market.
More information about the Company, including financial information, can be found on the ASFX web site at www.americansci.com.
Safe Harbor
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
CONTACT: Ronald Garner of AudioStocks.com, Investor Hotline:
+1-760-692-1167